The <i>MYCN</i> Enigma: Significance of <i>MYCN</i> Expression in Neuroblastoma
Xao X. Tang(University of Illinois Chicago), Naohiko Ikegaki(University of Illinois Chicago), Nai‐Kong V. Cheung(Memorial Sloan Kettering Cancer Center), Susan L. Cohn(Comer Children's Hospital), Huaqing Zhao(Children's Hospital of Philadelphia), Robert C. Seeger(Ottawa Hospital), Bing Kung(Children's Hospital of Philadelphia), Sakeenah L. Hicks(Emory University), Audrey E. Evans(Purdue University West Lafayette), David Y. Kim(Children's Hospital of Philadelphia)
Cited by 89
Related Papers
Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.
|Journal of Clinical Oncology|1993|2.3k
Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome
|Critical Care Medicine|2015|858
International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma.
|Journal of Clinical Oncology|1988|608